During Open Access Week 2020 and one year after the launch of the Open Pharma position statement on open access, we bring together stakeholders from different backgrounds to share their perspectives on open access publishing of pharma-sponsored research.
What medical communications has taught me that academia didn’t
One month into my role at Oxford PharmaGenesis has taught me more about scientific and medical publishing than 6 years in the world of academic research. Here, I discuss some of the key issues around academic publishing, and how some researchers in academia could learn from best practices developed to ensure compliance, transparency and integrity in the medical communications industry.
Evidence-based medicine no more?
In a pre-COVID-19 world, this week would have seen evidence-based medicine experts gather in Toronto for EBM Live 2020. However, like many other meetings during the pandemic, it has been postponed. Here, I reflect on last year’s meeting and pharma’s journey in improving the reporting of clinical trials.
Reproducible research and industry partnership jointly generate high-impact scientific discoveries
The hallmarks of sound science are reproducibility and generalizability that have been subjected to scientific peer review. If any of these characteristics is missing, science is lost. It sounds very simple, but anomalies and deficiencies are everywhere.
Ways to increase transparency, trust and patient involvement in pharma-funded publications – insights from the virtual 16th Annual Meeting of ISMPP
This year, the Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) went virtual. With a mix of engaging live and recorded sessions, 15 roundtables and over 45 posters to delve into, we share some of the highlights from the meeting.
“Pharma are doing ok in terms of open access, but they could be doing more” – insights from the Open Pharma June roundtable meeting
Open Pharma Members, Supporters and key Advisers came together to discuss the ways in which the scientific publishing community can make research accessible, discoverable and transparent for patients and the public.
Guest post: The open road
For many stakeholders within the healthcare industry, the world of open research is an exciting yet occasionally confusing one. At the start of this year, key industry players from across the pharma industry met in Oxford for a roundtable discussion hosted by Wiley on ‘How the pharma–publisher relationship should evolve in the new world of … Continue reading Guest post: The open road
New research in overall support of the Evidence [Aid]
Humanitarians working in crisis zones need real-time access to evidence. A recent study from McMaster University in Canada explored the effectiveness of Evidence Aid’s resource collections on critical decision-making
CBMRT US Biomedical Transparency Summit newsletter
The Center for Biomedical Research Transparency (CBMRT) hosts a free 5-year Biomedical Transparency Summit (BMTS) series in the US and Europe. The goal of BMTS is to promote discussion and collaboration on transparency across the global biomedical research ecosystem
Linking Evidence to Aid researchers in tackling the 2019 novel coronavirus outbreak
As the collection of literature and resources on the 2019 novel coronavirus outbreak increases, Evidence Aid is working to ensure links to the latest research are made discoverable